Fonte: Clinical and Investigative Medicine. Nome do evento: International Congress of Immunology. Unidade: FM
Assuntos: INFARTO DO MIOCÁRDIO, ARTERIOSCLEROSE CORONÁRIA (COMPLICAÇÕES), RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RONCHINI, K. R. O. M. et al. HIV patients with low CD4 counts with or without lipodystrophy show a maintained inability to produce antibodies against modified Low Density Lipoprotein (mLDL) or an Immunodominant Epitope from degraded apolipoprotein B (apo B). Clinical and Investigative Medicine. Montreal: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 01 jun. 2024. , 2004APA
Ronchini, K. R. O. M., Duarte, A. J. S., Casseb, J. S. R., Juliano, M. A., Juliano, L., & Gidlund, M. A. (2004). HIV patients with low CD4 counts with or without lipodystrophy show a maintained inability to produce antibodies against modified Low Density Lipoprotein (mLDL) or an Immunodominant Epitope from degraded apolipoprotein B (apo B). Clinical and Investigative Medicine. Montreal: Faculdade de Medicina, Universidade de São Paulo.NLM
Ronchini KROM, Duarte AJS, Casseb JSR, Juliano MA, Juliano L, Gidlund MA. HIV patients with low CD4 counts with or without lipodystrophy show a maintained inability to produce antibodies against modified Low Density Lipoprotein (mLDL) or an Immunodominant Epitope from degraded apolipoprotein B (apo B). Clinical and Investigative Medicine. 2004 ; 27( 4): 80A.[citado 2024 jun. 01 ]Vancouver
Ronchini KROM, Duarte AJS, Casseb JSR, Juliano MA, Juliano L, Gidlund MA. HIV patients with low CD4 counts with or without lipodystrophy show a maintained inability to produce antibodies against modified Low Density Lipoprotein (mLDL) or an Immunodominant Epitope from degraded apolipoprotein B (apo B). Clinical and Investigative Medicine. 2004 ; 27( 4): 80A.[citado 2024 jun. 01 ]